Home›Companies›Biotech & Pharma›AminoSense

AminoSense, Inc.

Develops tools for people to measure amino acid levels at home in real time.

Updated Nov 11, 2026·Latest SEC filing Mar 6, 2026·Suggest an edit

About AminoSense

AminoSense is a private company based in Montclair, New Jersey, incorporated in 2023 in Delaware. It has reported $1,416,621 raised in one offering on Form D since March 2026. Its chief executive is Aryeh Ganz.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 26, 2026Mar 6, 2026$1,416,621of $1.5M target2$708KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on AminoSense's Form D filed Mar 6, 2026.

Aryeh Ganz
Aryeh Ganz
Co-founder & CEO, director
Also a co-founder & executive chairman at Caffree and a director at Ilant Health.

Sources

  1. SECAminoSense, Inc. filing history
  2. CompanyAminoSense terms of use